Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
LONDON, Oct. 29 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel,
anti-inflammatory drugs, announced today the preliminary results from its
recently completed Phase II equivalent study of MRX-4, in a nasal aerosol
formulation, in 10...
New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
Data Also Showed That Over a 6 Month Period, Nasacort AQ Did Not Cause Significant Adrenal Suppression in This Same Age Group
BRIDGEWATER, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Data presented at
the American College of Allergy, Asthma & Immunology (ACAAI) annual meeting
suggests tha...
Allergic Rhinitis Associated with Impaired Sleep Quality
CHICAGO - Patients with allergic rhinitis, such as that caused by hay fever and other allergies, have more difficulty sleeping and more sleep disorders// than those without allergies, according to a report in the September 18 issue of Archives of Internal Medicine, a theme issue on sleep.
All...
Researchers Hint At The Probability Of A Link Between Rhinitis And Parkinson’
The latest research studies indicate that millions of people who suffer from chronic allergies to pets, dust and spores are three times// more likely to develop Parkinson’s disease later in life.
A study by US scientists, from the Mayo Clinic has shown that people who suffer from allergic rhi...
FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
Food and Drug Association as approved the drug CLARINEX-D 12 HOUR for use in treating symptoms of seasonal allergic rhinitis. // CLARINEX-D 12 HOUR is a drug containing a combination of desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg. FDA has approved the drug for use in persons abov...
Scientists Zero In on Elusive 'Allergy Gene'
...in an effective skin barrier against the environment -- significantly increase the risk for developing allergic sensitization, atopic eczema, allergic
rhinitis and asthma in people with eczema.
The link between atopic eczema and filaggrin gene mutations appeared to be particularly strong, the study found....
Lupin Expands Branded Play
...al symptoms associated with both seasonal allergic
rhinitis (SAR) and perennial allergic
rhinitis (PAR) in adults and children twelve (12) years of ...e a share out of the multi-billion dollar allergic
rhinitis market. AllerNaze(TM) offers a quality intra-nasal...
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
...ocular itching associated with allergic conjunctivitis.
Bepotastine was approved in Japan for use as a systemic drug in the treatment of allergic
rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively, and is marketed by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku C...
Many Overweight Kids Not Getting a Good Night's Sleep
...re, according to information from the AASM. Mild cases might be marked by persistent snoring due to nasal anatomic features such as chronic sinusitis,
rhinitis and nasal drain. Severe cases may include obstructive sleep apnea, a potentially dangerous condition in which breathing repeatedly starts and stops th...
ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
...ocular itching associated with allergic conjunctivitis.
Bepotastine was approved in Japan for use as a systemic drug in the treatment of allergic
rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively, and is marketed by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku C...
Rhinitis in Medical Technology
New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
BRIDGEWATER, N.J., March 15 /PRNewswire-FirstCall/ -- Data presented at
the annual meeting of the American Academy of Allergy Asthma & Immunology
(AAAAI) suggests that the continuous use of intranasal corticosteroid
Nasacort AQ (triamcinolone acetonide) Nasal Spray had no treatment effect
on s...
Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
LONDON, Jan. 16 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel anti-
inflammatory drugs, today announced the preliminary safety results from its
Phase I safety and tolerability study of MRX-4 in 16 patients suffering
from allergic...
VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
First Selective TLR8 Agonist to Advance for Treatment of Allergy
SAN DIEGO , April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and inflammatory ...
Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
LONDON, June 24 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, today announced that it has initiated a Phase II
equivalent study of MRX-4, in a nasal aerosol formulation, in 105 patients
suffering from all...
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
LONDON, June 11 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, today announced that it has obtained regulatory
approval from the South African Medicines Control Council (MCC) to initiate
a Phase II study o...
New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis
Study Also Demonstrated Significant Improvement in Eye Symptoms
DALLAS, Nov. 11 /PRNewswire/ -- Veramyst(TM) (fluticasone furoate)
Nasal Spray demonstrated significant improvement in the treatment of nasal
and ocular allergy symptoms of perennial allergic
rhinitis (PAR) in
patients 12 year...
Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
LONDON, Oct. 23 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, today announced the initiation of a Phase I
tolerance study of MRX-4 in 16 patients suffering from allergic rhinitis
(AR). The randomized, pl...
Inspire Announces Positive Results of Phase 2 Trial of Epinastine
Nasal Spray for Seasonal Allergic Rhinitis
DURHAM, N.C.--(BUSINESS WIRE)--May 8, 2007 - Inspire
Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced results of a
Phase 2 dose-ranging clinical trial comparing epinastine nasal
spray and placebo in patients with seasonal allergic rhinitis. For
the primary endpoint of improvement in total nasal...
Cobalis Reports Phase III Trial Results for PreHistin in Seasonal
Allergic Rhinitis
IRVINE, Calif.--(BUSINESS WIRE)--Jul 6, 2007 - Cobalis Corp.
(OTCBB:CLSC), a pharmaceutical development company specializing in
anti-allergy medications, today reported preliminary top-line
results from two Phase III clinical trials for its drug
PreHistin(TM) in patients with moderate to moderately...
DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
...nce the early 1970s as the active pharmaceutical ingredient in a nasal spray and in a metered-dose inhaler for the treatment of patients with allergic
rhinitis and asthma. orBec(R) is formulated for oral administration as a single product consisting of two tablets; one tablet is intended to release BDP in th...
Rhinitis in Medical Definition
Pathology
...er respiratory tract infection - Common cold -
rhinitis - Sinusitis - Pharyngitis - Tonsillitis - ...r diseases of upper respiratory tract
Vasomotor
rhinitis - Hay fever - Atrophic
rhinitis - Nasal polyp - Adenoid hypertrophy - Perito...
Rhinitis in Medical Dictionary
Rhinitis
Rhinitis , commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of
rhinitis is nasal dripping. It is caused by chronic or acute... ... Allergist on
Rhinitis . Allergies, including allergic r...
Vasomotor rhinitis
Rhinitis , commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of
rhinitis is nasal dripping. It is caused by chronic or acute... Vasomotor
rhinitis affects millions of Americans and resu...
Allergic rhinitis
Rhinitis , commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of
rhinitis is nasal dripping. It is caused by chronic or acute...
Rhinitis , commonly known as a runny nose, is the medical te...
Sneezing
...o be an allergic reaction, both to airborne substances and to ... Allergy is a the body's reaction caused when the immune system mistakenly ...
rhinitis - nasal stuffiness, sneezing , nasal itching, nasal discharge, itching ... Sneezing can send small particles from the nose at up to 100 ... ...
Hay fever
...inflammation of some internal areas of the nose. The primary symptom of
rhinitis is nasal dripping. It is caused by chronic or acute... Learn about t...r season varies with ... Hay fever , which is also called allergic
rhinitis , is a common allergic condition. ... Hay fever usually occurs when ai...
Epistaxis
... Ear, Nose, Throat, and Dental Disorders. Endocrine and Metabolic Disorders. Eye ... Introduction· Bacterial Infections·Foreign Bodies· Nasal Polyps·
rhinitis ... Nosebleeds ( Epistaxis ) What is epistaxis ? Epistaxis is bleeding from the nostril. At least 11% of all Americans have at least one nos...
Chronic
...ic bishop rage ... Providing an overview of coughing and its causes, symptoms, and treatment. Information on post nasal drip and chronic
rhinitis includes symptoms such as itchy runny nose, sneezing, itchy eyes, ears, and throat, and nasal congestion. Read about the complications of emphyse...
Barotitis
..... Barotitis media. A Medical Article provided by The University of Maryland Medical ... Risk factors for barotitis media include: * Allergic
rhinitis * Cerumen ... for the prevention of barotitis media: a controlled clinical trial in underwater divers. ... Ear Barotrauma ( Barotitis Media,...
Rhinitis in Biological News
Alcohol is associated with risk of perennial allergic rhinitis
There is a link between alcohol consumption and increased risk of perennial allergic rhinitis, according to a recent Danish study of 5,870 young adult women. The study, published in the July issue of Clinical and Experimental Allergy , found that the risk increased 3% for every additional alcoh...
Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants
...edominant allergen, the "Blo t 5" protein, in B. tropicalis, which is responsible for 60-70% of allergy cases in Singapore, including asthma, allergic
rhinitis and eczema.
Optimizing the potency of a genetic vaccine against the dust mite will be the focus of her second grant, while the third project will ...
The Clorox Company's new indoor allergen product reduces common indoor allergens up to 90 percent
... "Clorox® Anywhere® Anti-Allergen Fabric Spray offers families who want to manage exposure to indoor allergens* another option."
Allergic
rhinitis affects an estimated 20 to 40 million people in the United States alone, and the incidence is increasing. In fact, about 15 percent of the population...
Munich researchers discover key allergy gene
...ibodies then work in conjunction with certain cells to get rid of the allergens, a process that gives rise to the symptoms of allergy such as allergic
rhinitis (hay fever), atopic dermatitis or asthma.
"Most people with allergies are atopic - meaning they have a genetic tendency to develop allergies. To de...
Snoring in children might be an allergic type disease
...ediatric Pulmonology has established children with
rhinitis who were first born, were exposed to maternal toba...
219 children within the original study group had
rhinitis and of these, 213 could provide information on sno...en and is partly due to all of the children having
rhinitis which is often found in children who snore.
...
Rhinitis in Biological Technology
Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
LONDON and NEW YORK, Nov. 6 /PRNewswire/ -- Morria Biopharmaceuticals
Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs,
today announced positive data from its ICH compliant Phase II equivalent
multi-center study of MRX-4 (n=105) in patients suffering from allergic
rhi...
AOBO Announces New Product Launch
...n of a broad range of
prescription and over the counter ("OTC") products in China, today announced
that the Company has launched a new product for the
rhinitis and allergy
market, called Jingwei Capsules ("Jingwei"). Jingwei will be manufactured by
the Company's Boke subsidiary, and will be marketed througho...
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
... States and worldwide since the early 1970s as the active pharmaceutical ingredient in inhalation products for the treatment of patients with allergic
rhinitis and asthma. orBec((R)) and oral BDP are currently in development by DOR for the treatment and prevention of GVHD, the prevention of acute radiation e...
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
...nce the early 1970s as the active pharmaceutical ingredient in a nasal spray and in a metered-dose inhaler for the treatment of patients with allergic
rhinitis and asthma. orBec(R) is formulated for oral administration in GI GVHD patients as a single product consisting of two tablets; one tablet is intended ...
Knocking the Wind Out of Asthmatics: Help from Hippocrates
...he test is quickly becoming recognized as a way to safely and effectively avoid chronic inflammatory and allergy like problems, like asthma, perennial
rhinitis and skin problems, but also metabolic disorders that interfere with weight loss, and other inflammatory conditions such as arthritis and migraine, wit...
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
...dustry, initially at Astra, USA in Westborough, MA working on inhaled steroids (Rhinocort Aqua and Pulmicort Turbuhaler) for the treatment of allergic
rhinitis and asthma, including three successful new drug applications for these products. He has worked with several pharmaceutical and biotechnology companies...
Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'
...or the relief of symptoms associated with allergic
rhinitis (seasonal and perennial) and the treatment of unco...eople in the United States.
Seasonal allergic
rhinitis (SAR), commonly referred to as "hay fever" or "out...es, and weeds, as well as mold. Perennial Allergic
rhinitis (PAR) is sometimes referred to as "year round" or ...
Axikin Pharmaceuticals Spins out of Actimis
... target research programs. These programs are expected to have broad applications across respiratory and allergic diseases including asthma, allergic
rhinitis and chronic obstructive pulmonary disease (COPD) with, potentially, broader applications in inflammation, autoimmunity, oncology and cardiovascular di...
ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
...against
the signs and symptoms of allergic conjunctivitis.
Bepotastine was approved in Japan for use as a systemic drug in the
treatment of allergic
rhinitis and urticaria/pruritus in July 2000 and
January 2002, respectively, and is marketed by Mitsubishi Tanabe Pharma
Corporation (formerly Tanabe Seiyaku C...
Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
...at The New York Palace Hotel.
Dr. Cohen's presentation will provide an overview of Morria's
development of its leading clinical programs in allergic
rhinitis (hay
fever) and skin inflammation (contact dermatitis), as well as its
pre-clinical progress in asthma, inflammatory bowel disease, ophthalmology
and ...